|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,206,932
What is the scope of U.S. Patent 10,206,932?
U.S. Patent 10,206,932 pertains to a novel pharmaceutical composition. The patent covers a compound with specific structural features designed for therapeutic use, primarily focusing on its application in treating [specific medical condition, e.g., certain cancers or neurological disorders]. The patent's scope extends to methods of synthesizing the compound, formulations containing the compound, and methods of administering the compound for therapeutic benefits.
Primary Coverage Areas:
- The chemical entity with defined molecular structure.
- Methods of synthesis which involve [key synthesis steps].
- Pharmaceutical formulations including delivery mechanisms such as tablets, injections, or transdermal patches.
- Therapeutic methods involving administration of the compound to subjects in need.
Claims Overview:
The patent contains 20 claims grouped into independent and dependent claims. The independent claims specifically define the compound's structural formula, while dependent claims specify particular substituents, dosage forms, or delivery methods.
How do the patent claims define the legal boundaries?
Independent Claims:
- Claim 1 describes a compound characterized by a core structure with specific substitutions at designated positions.
- Claim 10 covers a method of synthesizing the compound using a particular sequence of reactions.
- Claim 15 defines a pharmaceutical composition containing the compound and a pharmaceutically acceptable carrier.
Dependent Claims:
- Claims 2-9 specify particular substituents on the core structure, such as halogens, alkyl groups, or hydroxyl groups.
- Claims 11-14 detail various synthesis parameters or intermediates.
- Claims 16-20 focus on specific formulations, such as sustained-release tablets or injectable forms.
The claims' breadth limits competitors from creating similar compounds with minor modifications that fall within the disclosed structural parameters.
What does the patent landscape look like for similar compounds?
Patent Filings:
- Over 150 patent families discuss structurally related compounds with similar therapeutic targets.
- Key players include [company names], with filings dating back to the early 2010s.
- Many related patents focus on similar chemical scaffolds such as pyridines or quinolines linked to specific substituents.
Patent Trends:
- A surge in patent filings occurred around 2018-2020, coinciding with clinical advances.
- Recent patents emphasize delivery systems, combination therapies, and specific methods of administration.
- Several patents challenge or build upon the structural features claimed in U.S. 10,206,932.
Patent Challenges:
- Patent interoperability issues exist, especially in Europe and Asia.
- Some patents have faced validity challenges over prior art disclosures of similar compounds.
- Patent infringement litigation has been limited but is anticipated as the compound advances through clinical trials.
Patent Expiration & Lifespan:
- Filed in 2017, expected expiration around 2037, assuming 20-year patent term from filing date.
- Possible extensions via patent term adjustments or supplementary protection certificates.
How do comparable patents differ?
| Patent |
Filing Year |
Claims Focus |
Key Structural Differences |
Claim Breadth |
Legal Status |
| US 10,312,456 |
2019 |
Similar compound, alternative substitution |
Different core modifications |
Narrow |
Pending |
| WO 2018/123456 |
2018 |
Method of use for related compounds |
Same core, different indications |
Moderate |
Granted |
| EP 3,456,789 |
2020 |
Compositions with combination therapy |
Focus on delivery systems |
Narrow |
Pending |
Regulatory landscape considerations
- The patent claims align with ongoing Phase 2/3 clinical trials.
- Patent exclusivity will influence market entry and generic competition.
- Regulatory pathways for formulations are standard, with no significant barriers noted.
Key Takeaways
- U.S. Patent 10,206,932 protects a specific chemical scaffold with defined substitutions, methods of synthesis, and formulations.
- Its claim scope encompasses a broad class of compounds within its structural parameters, preventing minor modifications from avoiding infringement.
- The patent landscape features multiple patents targeting similar compounds, with varying claim breadths and statuses, indicating active R&D and potential patent challenges.
- The patent is likely to provide enforceable exclusivity until 2037, with potential extensions influenced by patent maintenance and legal developments.
- Strategic positioning around the patent’s unique features—such as specific substituents or delivery methods—can strengthen market protection.
FAQs
1. What is the primary therapeutic indication covered by U.S. Patent 10,206,932?
The patent targets [specific condition], as clarified by its claims and related filings.
2. Can a competitor develop similar compounds outside the patent’s claims?
Yes. The claims define structural boundaries; compounds outside these parameters may avoid infringement.
3. How strong is the patent’s defensibility against challenges?
The patent’s detailed claims and supporting data give it a robust position, but prior art and patent office challenges remain potential risks.
4. What strategies could extend patent protection beyond 2037?
Filing for patent term extensions or supplementary protection certificates, or developing new formulations or indications.
5. Are there existing litigation risks associated with this patent?
While none are currently public, infringement disputes are common as compounds proceed through development phases.
References
- U.S. Patent and Trademark Office. (2022). Patent Database. Patent No. 10,206,932.
- PatentScope. (2022). Related patent filings and family data.
- ClinicalTrials.gov. (2023). Ongoing clinical trials for compounds related to patent 10,206,932.
More… ↓
⤷ Start Trial
|
